Medical/Pharmaceuticals
Avance Clinical Receives Frost & Sullivan's 2026 Global Company of the Year Recognition for Excellence in Biotech CRO Leadership
The company is recognized for its innovation, scientific expertise, and
customer-centric clinical development model in the global biotechnology CRO
market
SAN ANTONIO, May 12, 2026 /PRNewswire/ -- Frost & Sullivan
2026-05-12 20:00
2285
New Data Show Gaps in Antiviral Pipeline Against High-Risk Viral Threats
Longitudinal analysis reveals clear gaps in global preparedness against emerging viral threats and future pandemics. CAMBRIDGE, Mass., May 12, 2026 /PRNewswire/ -- New global analysis of antiviral compounds released today has identified a critically thin pipeline of treatments in development tha...
2026-05-12 19:00
2081
HKSH Medical Group Named Asia's first Photon-Counting CT Simulator Reference Site, Bringing Global Impacts on Precision Medicine and Medical Imaging with Siemens Healthineers
HONG KONG, May 12, 2026 /PRNewswire/ -- HKSH Medical Group (HKSH) and global medical technology leader Siemens Healthineers today signed a collaboration agreement at the "Asia Summit on Global Health", establishing HKSH as Siemens Healthineers' first Photon‑Counting Computed Tomography Simulator ...
2026-05-12 17:31
2952
BGI Genomics joins HGP2 Rare Disease Alliance to Close Rare Disease Care Gap in Asia-Pacific
KUALA LUMPUR, Malaysia, May 12, 2026 /PRNewswire/ -- The HGP2 Rare Disease
Alliance of the Asia-Pacific Region (HGP2 RaDiAnce–APAC
2026-05-12 16:25
3847
DNA 'barcodes' help NUS researchers pinpoint gold nanoparticles that can strike cancer at its power source
A new high-throughput platform screens dozens of nanoparticle designs in living systems to identify those that reach tumour mitochondria, enabling more precise and effective cancer therapies SINGAPORE, May 12, 2026 /PRNewswire/ -- Researchers at the National University of Singapore (NUS) have de...
2026-05-12 14:59
4814
GIP Moves from Supporting Role to Key Variable: BrightGene Bio-Medical's Phase III Results Signal Differentiation in Weight Loss Arena
SUZHOU, China, May 12, 2026 /PRNewswire/ -- As competition in the weight loss drug market progressively intensifies, the latest Phase III clinical data disclosed by BrightGene Bio-Medical (688166.SH) for BGM0504 has reignited market attention. Mean weight reduction of 19.3%, waist circumference ...
2026-05-12 14:08
2531
Hengrui Pharma and Bristol Myers Squibb Announce Strategic Agreements to Advance Innovative Medicines Across Oncology, Hematology, and Immunology
Landmark collaboration leverages complementary capabilities to drive speed in early innovation and help advance medicines for patients worldwide Agreements include 13 programs with the potential to address significant unmet patient needs and support long‑term growth SHANGHAI and PRINCETON, N.J.,...
2026-05-12 12:27
2811
NYSE Content Update: Eli Lilly to Celebrate 150 Years of Scientific Innovation
NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, May 11, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins...
2026-05-11 21:16
5844
Ranok Therapeutics Announces the Publication of Positive Phase 1a Clinical Results for KRAS G12D Inhibitor RNK08954 in Cancer Discovery
BOSTON and HANGZHOU, China, May 11, 2026 /PRNewswire/ -- Ranok Therapeutics, a clinical-stage biotechnology company developing innovative therapies, today announced the publication of preliminary clinical results from its Phase 1a study of RNK08954 in the peer-reviewed journal Cancer Discovery. R...
2026-05-11 21:00
4485
Leads Biolabs R&D Symposium: Platform Synergy and Multi-Mechanism Integration Reshape the Immuno-Oncology Landscape
NANJING, China, May 11, 2026 /PRNewswire/ -- Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs"; Stock Code: 9887.HK) successfully held its R&D Symposium in Shanghai. Under the theme "Leads Innovation, Future Forward", the event comprehensively presented the Company's strategic elevation from "mul...
2026-05-11 19:00
3215
Putting humanity back into the focus of 'technonatalism' in assisted reproduction
BEIJING, May 11, 2026 /PRNewswire/ -- Since the world's first IVF baby was born almost 50 years ago, assisted reproductive technologies have advanced spectacularly to help millions of infertile couples to achieve their dreams of parenthood. Yet, despite the power of so-called technonatalism hu...
2026-05-11 17:42
3157
Planning a Group Visit to Medtec Shanghai: A Corporate Buyer's Guide
SHANGHAI, May 11, 2026 /PRNewswire/ -- Sourcing complex medical device
components is rarely a solo job. Building a secure supply chain requires direct
input from product engineering, quality control, and executive procurement
teams. Sending your entire group to theMedtec China exhibition
2026-05-11 14:45
2424
Avalere Health expands to Japan with a full-service Advisory, Medical, and Marketing offering, led by industry veteran Junji Yokokawa
Avalere Health Japan is designed with the full healthcare experience in mind, launching with an elite integrated team that brings together market access, medical, and marketing specialists, along with strategic consulting expertise. TOKYO, May 11, 2026 /PRNewswire/ -- Avalere Health, a global str...
2026-05-11 13:30
1986
ACROBiosystems Launches Global License Solution Upgrade for HEK293 Functional Cell Lines, Streamlining Compliance to Accelerate Biopharmaceutical R&D
TOKYO, May 11, 2026 /PRNewswire/ -- ACROBiosystems announced a major upgrade to its global license solution for HEK293 functional cell lines. Centered on customer value and empowering global biopharmaceutical innovation, the upgrade simplifies compliance workflows to support efficient drug discov...
2026-05-11 08:00
2505
ACROBiosystems Launches Global License Solution Upgrade for HEK293 Functional Cell Lines, Streamlining Compliance to Accelerate Biopharmaceutical R&D
SEOUL, South Korea, May 11, 2026 /PRNewswire/ -- ACROBiosystems announced a major upgrade to its global license solution for HEK293 functional cell lines. Centered on customer value and empowering global biopharmaceutical innovation, the upgrade simplifies compliance workflows to support efficien...
2026-05-11 08:00
2387
Study pinpoints 45 years as the critical threshold for a significant downturn in male fertility
BEIJING, May 10, 2026 /PRNewswire/ -- Forty-five years has been identified as the critical age threshold at which elevated sperm DNA fragmentation significantly reduces fertility potential in men. High levels of DNA fragmentation, defined as a breakdown of genetic material inside sperm cells, ...
2026-05-10 17:00
3060
ACROBiosystems Launches Global License Solution Upgrade for HEK293 Functional Cell Lines, Streamlining Compliance to Accelerate Biopharmaceutical R&D
NEWARK, Del., May 9, 2026 /PRNewswire/ -- ACROBiosystems has implemented a major upgrade to its global licensing framework for HEK293 functional cell lines, transitioning from a complex administrative process to a streamlined, purchase-based authorization model. This policy shift addresses the i...
2026-05-10 01:30
4832
South and East Asia identified as hotspots of global warming related impacts on male fertility
BEIJING, May 9, 2026 /PRNewswire/ -- A major new study has shown that South and East Asia dominate patterns of global warming related decline in male fertility with the strongest and most consistent evidence coming from India, Pakistan and the southern parts of China. The effects of increased ...
2026-05-09 15:01
4394
Psychosocial support is vital to help those living with infertility to overcome treatment barriers, including stigmas, myths and taboos about IVF
BEIJING, May 9, 2026 /PRNewswire/ -- Diverse cultural or religious values across the Asia Pacific region mean that many people living with infertility face challenging family or societal attitudes when considering assisted reproductive treatment to achieve their dreams of parenthood. In many c...
2026-05-09 09:00
4622
World's First | Mabwell's 9MW5211 Receives FDA Clearance for Clinical Trial Application
SHANGHAI, May 8, 2026 /PRNewswire/ -- Mabwell (688062.SH, 02493.HK), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that the Investigational New Drug (IND) application for 9MW5211, its independently developed novel antibody, has received clearance...
2026-05-09 08:00
4078
Week's Top Stories
Most Reposted
Two-day Global Prosperity Summit 2026 officially opens
[Picked up by 308 media titles]
2026-05-19 23:59
Visa and Trip.com Group Ink Strategic Collaboration, Enabling Consumers to Chase Their Passions Through Travel
[Picked up by 308 media titles]
2026-05-19 18:10
Two‑day Global Prosperity Summit 2026 concludes successfully
[Picked up by 303 media titles]
2026-05-21 22:13
Hyundai Motor Group to Pioneer Hong Kong's Hydrogen Economy, Accelerating Asia-Pacific Expansion
[Picked up by 290 media titles]
2026-05-18 15:30
Autonomous AI marketing platform Protaigé launches with Maia, the world's first AI Account Director that operates within the flow of work
[Picked up by 280 media titles]
2026-05-20 09:15Most Read
PT Telkom Indonesia (Persero) Tbk 2025 Annual Report on Form 20-F
2026-05-16 00:26
7319
Eyes that photosynthesise: NUS scientists plant a cure for dry eye disease
2026-05-16 11:14
5337
Lepro Introduces STV1, a TV Backlight That Combines Screen Sync, AI Lighting, and Easier Setup
2026-05-16 00:00
5039
NYSE Content Update: Exchange Turns 234 Ahead of U.S. Semiquincentennial
2026-05-18 21:29
5010
NYSE Content Update: Armada Raises $230 Million, Boosts Valuation to $2 Billion
2026-05-19 21:02
4914
